🇺🇸 FDA
Patent

US 12227479

Dihydropyridines for the treatment of cognitive impairment or traumatic brain injury

granted A61PA61P25/28

Quick answer

US patent 12227479 (Dihydropyridines for the treatment of cognitive impairment or traumatic brain injury) held by United States Government as represented by the Department of Veterans Affairs expires Mon Feb 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
United States Government as represented by the Department of Veterans Affairs
Grant date
Tue Feb 18 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61P, A61P25/28